Linked Life Data

16417723

Source:http://linkedlifedata.com/resource/pubmed/id/16417723

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-1-18
pubmed:abstractText
The availability of recombinant FSH and LH opens an opportunity to individualize ovarian stimulation. While the need for FSH is universal, a question remains whether exogenous LH is beneficial. Previous research on adding LH to an unselected group of patients failed to demonstrate any advantage. Indeed, it may seem presumptuous to expect that all patients will respond in the same manner. Recent studies hint that LH supplementation should be individualized. These studies indirectly suggest that the changes in LH concentration may be more important than the concentration per se. The growing follicle, and particularly oestradiol biosynthesis, may be sensitive to decreases in LH concentrations. The challenge is to identify the patient whose LH will drop during stimulation. This individualized approach will assure that supplemented LH will only be given to those who need it.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1472-6483
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
664-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
To add or not to add LH: consideration of LH concentration changes in individual patients.
pubmed:affiliation
Department of Obstetrics and Gynecology, Rambam Medical Centre, POB 9602, Haifa 31096, Israel. skol@rambam.health.gov.il
pubmed:publicationType
Journal Article, Review